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Abstract
Background and Objective: Advanced analytic methods for synthesizing evidence about complex interventions continue to be devel-
oped. In this paper, we emphasize that the specific research question posed in the review should be used as a guide for choosing the appro-
priate analytic method.
Methods: We present advanced analytic approaches that address four common questions that guide reviews of complex interventions:
(1) How effective is the intervention? (2) For whom does the intervention work and in what contexts? (3) What happens when the
intervention is implemented? and (4) What decisions are possible given the results of the synthesis?
Conclusion: The analytic approaches presented in this paper are particularly useful when each primary study differs in components,
mechanisms of action, context, implementation, timing, and many other domains.  2017 The Author(s). Published by Elsevier Inc. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
This is the fifth of a seven-part series of papers providing
tools and approaches for conducting reviews of complex
interventions. This paper presents advanced analytic
methods that can be applied to systematic reviews of
complex interventions.
This paper seeks to update earlier work [1,2,3] with an
overview of analytic methods that can address synthesis
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questions involving complex interventions. Reviews of com-
plex interventions (defined by Guise et al. [4]) where
complexity is considered important frequently seek to address
several questions within a single review about the intervention
and the health system within which it is implemented.
As described in the fourth paper in this series by
Viswanathan et al. [5], decisions about how to conduct a
review of a complex intervention depend on a number of
factors such as the nature and extent of the existing
evidence and the resources available for the review.
In this paper, we emphasize the nature of the decision or,
in other words, the specific research question posed in the
review as a guide to the appropriate analytic method to
address that question. We focus on methods that address
four broad questions about complex interventions:
(1) How effective is the intervention? (2) For whom is
the intervention effective and in what contexts? (3) What
happens when the complex intervention is implemented?
and (4) What decisions are possible given the results of
the synthesis? Given space limitations, the discussion will
introduce analytic methods that can address these questions
about complex interventions and provide pointers to
resources for interested readers to gain expertise. Table 1
provides a summary of the types of questions asked about
complex interventions and analytic strategies used to
support these questions. The analytic techniques discussed
here are not unique to reviews of complex interventions.
They do, however, address the most common questions
for reviews concerned with complexity.
2. How effective is the intervention?
Systematic reviews of complex interventions may start
with a relatively simple question that does not necessarily
explore complexity: Does the intervention, in general,
work? Although each example of the intervention may
differ from others in components, mechanism of action,
context, implementation or other major domains, policy
makers may still be interested in whether the complex inter-
vention works better than, say, usual care. Methods for
assessing the overall effectiveness of an intervention are
well established in the literature and are covered in detail
elsewhere [6]. We note, however, that new analytic
approaches continue to be developed to address questions
focused on the overall effectiveness of an intervention, or
the comparative effectiveness of interventions, for example,
network meta-analysis [7,8], and single-case designs [9,10].
Some interventions are so complex (such as slum upgrad-
ing, see Turley et al. [23]) that multiple effects and impacts
are determined at different levels of the health system to
provide a suite of different options to consider.
When studies of complex interventions examine multi-
ple outcomes, methods such as multivariate meta-analysis
[11] can be used to examine the average effect for a number
of dependent outcomes. Another alternative is to use
weighted least-squares estimates of average effect sizes
with robust estimation for standard errors [12] when studies
collect multiple outcomes on the same sample.
No matter what analytic strategy is used to examine the
average effect of a complex intervention, full reporting of
results is particularly important. Studies of complex inter-
ventions typically collect a range of outcomes, both benefi-
cial and harmful, at a number of levels of the system.
Estimates of effect size for all outcomes along with their
associated confidence intervals should be provided for each
analysis conducted. When appropriate, the consistency and
heterogeneity of these estimates should also be presented.
The literature on the effects of complex interventions is
emerging, and thus, there may not be a large number of
studies to use in a synthesis. Reporting on all the results
helps inform the design of future studies on the intervention.
3. For whom is the intervention effective and in what
contexts?
More often, we are focused on the question of whether
the effectiveness of the intervention varies because of
differences among studies in their context, participant
samples, or elements of the intervention actually imple-
mented. This question centers on the heterogeneity of the
intervention’s effects. Given the nature of a complex inter-
vention, we expect that treatment effects and impacts will
vary because of reasons related to the complexity of the
intervention itself. There are a number of methods that a
reviewer could use to examine how treatment effects from
a complex intervention vary across studies. Here, we will
present two general statistical modeling strategies that
could be used to examine heterogeneity: meta-regression
and finite mixture models.
4. Meta-regression
Meta-regression is a commonly used technique in meta-
analysis [13] and can prove useful in exploring heterogene-
ity in the context of complex interventions. Reviewers
should begin with an a priori theory about how the
effectiveness of a complex intervention may vary as a
function of intervention components, the context, the
Definition of complex interventions [4]
All complex interventions have two common characteristics: they have
multiple components (intervention complexity) and complicated/
multiple causal pathways, feedback loops, synergies, and/or
mediators and moderators of effect (pathway complexity). In
addition, they may also have one or more of the following three
additional characteristics: target multiple participants, groups, or
organizational levels (population complexity); require multifaceted
adoption, uptake, or integration strategies (implementation
complexity); or work in a dynamic multidimensional environment
(contextual complexity).
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implementation of the intervention, the participants, the
caregivers, and so on. A priori theory guards against
capitalizing on chance and issues of multiplicity which
are serious problems in meta-analysis [24]. Reviewers then
test a model using study and intervention characteristics as
predictors for variation in effect size.
Reviewers can take either a frequentist or Bayesian
approach to fitting a meta-regression model. In frequentist
meta-analytic models, the effect sizes we observe are
assumed to come from a process of sampling from a distri-
bution of effect sizes. Parameters are estimated only from
our sample at hand. In contrast, Bayesian methods for
meta-analysis [14] represent a different philosophical
approach to statistical inference. Specifically, Bayesian
inference applies Bayes’ theorem to a fully specified prob-
ability model, and the model includes two primary compo-
nents: (1) choosing prior distributions for each unknown
parameter such that it describes the uncertainty before the
analysis and (2) choosing appropriate sampling distribution
to describe the data. Bayes’ theorem then combines the
prior distributions of the parameters with the sampling dis-
tributions of the data to yield posterior distributions of the
model parameters. Thus, we use evidence from the data to
update what is known about our parameters, summarizing
the new information state using probability distributions.
Bayesian analysis can incorporate prior knowledge about
a complex intervention such as the likely extent of
between-study variation that we might have from other
sources.
5. Finite mixture modeling
Although meta-regression under either a frequentist or
Bayesian model is best used when the researcher has an a
priori model for heterogeneity, finite mixture modeling
takes a more exploratory approach. Reviewers may find
that not all of the relevant, observable characteristics are
reported in studies, and much unexplained heterogeneity
remains. A researcher might wish to explore whether there
are distinct groupings of intervention effects using finite
mixture modeling [15] in a manner similar to exploratory
factor analysis.
Finite mixture modeling, also known as latent class
modeling, falls within the structural equation modeling
framework. When researchers apply a finite mixture model
to the analysis of effect sizes, they assume that there are
distinct, latent classes or subpopulations of effect sizes
[16]. The researcher prespecifies the number of subpopula-
tions of effect sizes that need to be extracted and then uses
the results to make sense of the extracted latent classes
[17]. For example, a researcher may find that effect sizes
measuring the effectiveness of a complex intervention are
heterogeneous. Using finite mixture modeling, the
researcher finds that effect sizes cluster into two classes,
and this grouping of effect sizes into two classes accounts
for much of the heterogeneity. The researcher’s next task
is to examine potential reasons for the clustering of the
effect sizes into two groups to arrive at hypotheses for
the observed heterogeneity. Perhaps, the studies in one
cluster all include much younger and healthier patients than
those in the second cluster.
Finite mixture modeling offers a flexible framework for
meta-analytic data analyses. It is possible to accommodate
missing data and model random effects while testing meta-
analytic mixture models (including intervention effects on
univariate or multivariate outcomes as well as moderator
analyses) all within the single framework [16]. Most user-
friendly structural equation modeling software programs
(including, e.g., the frequently used Mplus software) allow
testing and estimation of finite mixture models and of more
typical meta-analytic research hypotheses.
Meta-regression and finite mixture modeling are two
methods used to explore heterogeneity of effect sizes in
the synthesis of complex interventions. Another method
under development for exploring heterogeneity is qualita-
tive comparative analysis [18,19]. Used within a systematic
review context, each individual study within the review
represents a case, and qualitative comparative analysis
is used to identify the combinations of intervention
components, implementation features, or contextual
Table 1. Analytic strategies for complex interventions
Complex intervention question Analytic strategies
How effective is the intervention? Single outcomes
 Random- and fixed-effects estimates of average effect [6]
 Network meta-analysis [7,8]
 Single-subject studies meta-analysis [9] Multivariate outcomes
 Multivariate meta-analysis, using methods such as multilevel modeling [10,11]
 Robust variance estimation [12]
For whom is the intervention effective
and in what contexts?
Meta-regression
 Frequentist [13]
 Bayesian [14] Finite mixture models (structural equation models
or latent class models) [15e17]
Qualitative comparative analysis [18e21]
What happens when the complex
intervention is implemented?
Choice of a wide range of designs, methodologies, and methods of evidence synthesis
What decisions are possible given the
results of the synthesis?
Decision analysis [22]
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characteristics (e.g., population, setting, etc.) that are asso-
ciated with effectiveness of an intervention, or alternatively,
ineffectiveness. Because qualitative comparative analysis is
a relatively new technique, and few examples exist, specific
standards for using the approach, conducting the analysis,
and reporting results are in evolution [20,21].
The use of any analytic method described previously has
limitations in the synthesis of complex interventions. One
issue involves the interpretation of the results from these
strategies. Models examining effect size heterogeneity
can only suggest associations among characteristics of
studies and variation in effect sizes. Causal inferences
about how or why effect sizes vary cannot be supported
by the use of these models. In addition, Berlin et al. [25]
and Schmid et al. [26] warn about the potential of aggrega-
tion bias when interpreting meta-regression, and, by exten-
sion, finite mixture modeling results. Relationships that
hold at the study level may not apply to how the interven-
tion operates at the level of the individual patient, and
interpretation of meta-regression should be restricted to
the study level. Careful use of these models can help
researchers explore the potential reasons for heterogeneity
in treatment effectiveness but may have limited use with
small numbers of studies of complex interventions coupled
with many potential sources of heterogeneity.
When examining heterogeneity in complex interventions,
results from all analyses should be reported, particularly any
sensitivity or subgroup analyses. This information is partic-
ularly important in the synthesis of complex interventions as
there are likely many different outcomes and subgroups to
examine. Given the number of decisions about the number
and types of analyses conducted, full and transparent report-
ing helps inform future syntheses and primary studies on the
complex intervention.
6. What happens when the complex intervention is
implemented?
For many complex interventions where heterogeneity
makes it difficult to undertake any meaningful synthesis
of intervention effects, the more important question is what
happens when the complex intervention is implemented
[27]. Understanding the intended and unintended impacts
of complex interventions in different contexts can provide
vital information to inform decision making. Evidence to
address questions about ‘‘what happens’’ is typically qual-
itative, quantitative, or mixed method (such as interviews,
focus groups, stakeholder surveys, etc.). In addition, Turley
et al. [23] suggest that synthesizing other types of quantita-
tive studies (e.g., controlled after intervention and uncon-
trolled before and after studies) not usually included in
traditional reviews can help understand the wider impacts
of interventions such as the association between interven-
tions and outcomes. Guidance is available to support re-
viewers in designing reviews to address ‘‘what happens’’
questions. Noyes et al. [27] have produced guidance on
choice of social theory to systematize review processes
and inform interpretation of evidence. The UK Medical
Research Council [28] has recently produced detailed guid-
ance on designing theory-informed process evaluations to
explore implementation, stakeholder experiences, and
impacts. The Medical Research Council’s process evalua-
tion guidance provides a clear framework of the types of
social theories that may be helpful and the types of
evidence that can be synthesized to better understand what
happens when a complex intervention is implemented. One
emerging strategy is the synthesis of trial-sibling studies.
Trial-sibling studies are studies of the implementation of
an intervention, which are linked with a randomized
controlled trial. If trial-sibling studies are not available,
Cochrane guidance recommends searching for and synthe-
sizing qualitative studies of similar interventions in similar
contexts unrelated to the included trials [29].
The Cochrane Qualitative and Implementation Methods
group provides guidance and signposting to appropriate
searching, appraisal, and synthesis methods to address
‘‘what happens’’ questions [30]. There are numerous meth-
odologies and methods from which to select an approach to
address specific types of ‘‘what happens’’ questions; far too
many to summarize here. The forthcoming update of the
Cochrane Handbook contains a new chapter on methods
for complex intervention synthesis. The key issue for
review authors to consider when selecting an appropriate
design, methodology, and method(s) is the ‘‘fit’’ with the
review questions and the type and quality of available
evidence as discussed in Viswanathan et al. in this series
[5]. The ‘‘fit’’ of review questions with review design and
methodology may not become apparent until the pool of
evidence is known and understood. Reviews of different
types of evidence may be undertaken separately and then
combined in an overarching synthesis or integrated within
a single review process. Table 2 outlines various
approaches and examples for integrating qualitative and
quantitative evidence.
High-quality methodological exemplars exploring
‘‘what happens when complex interventions are imple-
mented’’ are increasingly available; see for example, the
Cochrane qualitative evidence synthesis of the barriers
and facilitators to implementation of lay health worker pro-
grams [30,36] that is then integrated with the corresponding
effectiveness review using a logic model.
7. What decisions are possible given the results of the
synthesis?
Often researchers undertake a review of a complex inter-
vention to make a decision or take an action. In the context
of evidence synthesis to inform decision making about clin-
ical or public health interventions, ‘‘decision analysis’’ typi-
cally refers to the use of mathematical computer models to
40 T. Pigott et al. / Journal of Clinical Epidemiology 90 (2017) 37e42
estimate the probability of specific outcomes of interest of
two or more competing interventions. Based on the proba-
bilities of these outcomes and the implicit or explicit value
that the decision maker places on each outcome, the optimal
decision can be identified if there is consensus on the defi-
nition of ‘‘optimal.’’ In the setting of decisions where the
cost of the interventions are considered, this can be formally
defined as the decision maker’s ‘‘willingness to pay’’ for a
given level of health benefit [37]. In settings where costs
are not considered, estimates of the expected number of
harms and benefits with each option can be used, although
there has been much less consideration of the definition of
an acceptable ‘‘harm/benefit’’ ratio [38].
The real power of the method lies in the ability to quantify
the effect of uncertainty in the underlying probability
estimates that are included in the modeldclinical effective-
ness, probability of adverse events, costs of specific out-
comes [37]. Although decision modeling can be used in
the evaluation of simple interventions, such a framework is
especially powerful in the evaluation of complex interven-
tions where the available interventions may not be studied
in a single study, or where specific combinations of interven-
tions may not ethically be examined by an RCT. A decision
model allows the user to bring together evidence from
diverse sources, to explore novel combinations of interven-
tions, and to evaluate the gaps in the evidence and needs
for further data. Through sensitivity analysis (systematically
varying the value of specific parameters, either across a range
defined by the literature or expert opinion, or stochastically
using distributions obtained from the available evidence),
the impact of uncertainty in probabilities can be illustrated,
and the relative contributions of specific aspects of uncer-
tainty can be identified [22]. This, in turn, can be very useful
for identifying future research needs [39e41]. The method
can still be useful even if no direct estimates of a parameter
are available. For example, in the setting of a complex inter-
vention where there is uncertainty about uptake among
patients outside of a trial setting, the proportion of the pop-
ulation accepting the intervention, as well as the potential
impact of additional components of the intervention on
acceptability, can be varied to illustrate the impact of accept-
ability on overall health outcomes [40].
This flexibility also allows the model to predict out-
comes under different scenarios. For example, if there is
evidence of differential effectiveness in specific subgroups,
this can be modeled by changing the relevant parameters.
Subgroup-specific outcome probabilities can be combined
to estimate the population-level effect under different sub-
group distributions. In the setting of complex interventions,
the effect of differences in specific subgroups can be
modeled relatively easily.
8. Summary
The analytic methods discussed here provide tools for
addressing four of the key questions commonly asked about
a complex intervention: (1) How effective is the interven-
tion? (2) For whom is the intervention effective and in what
contexts? (3) What happens when the complex intervention
is implemented? and (4) What decisions are possible given
the results of the synthesis? The methods discussed here
can be used in the synthesis of any intervention but are
particularly useful when each primary study of the complex
intervention differs in components, mechanisms of action,
context, implementation, and many other domains. Future
methodological research is needed in developing methods
that fit or match the kinds of questions most important to
stakeholders.
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